|
|
|
|
LEADER |
01828nam a22003135i 4500 |
001 |
000295045 |
005 |
20210615080835.0 |
007 |
cr nn 008mamaa |
008 |
120829s2013 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781461436768
|
024 |
7 |
|
|a 10.1007/978-1-4614-3676-8
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a p53 in the Clinics /
|c edited by Pierre Hainaut, Magali Olivier, Klas G. Wiman.
|
250 |
|
|
|a 1st ed. 2013.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2013.
|
300 |
|
|
|a X, 358 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Foreword -- p53 activities and the hallmarks of cancer -- The inheritance of p53 -- p53: Guardian of the metabolome -- The p53 family and stem cell biology -- Mutant p53-driven tumorigenesis -- Humanized p53 mouse models -- p53 models for mammary carcinogenesis -- TP53 somatic mutations: Prognostic and predictive value in human cancers -- Assessing TP53 status in human tumors - lessons from breast cancer -- TP53 germline mutations: Genetics of Li-Fraumeni Syndrome -- TP53 gene therapy -- Upstream targets in the p53 pathway -- p53-reactivating molecules as research tools and anti-cancer drugs -- Restoring mutant p53 activity -- p53-immunotherapy of cancer -- Designing p53 trials: a surgical oncologist view -- p53 in the clinic: a pathologist view -- p53 in genetic counseling -- Index.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
700 |
1 |
|
|a Hainaut, Pierre.
|e editor.
|
700 |
1 |
|
|a Olivier, Magali.
|e editor.
|
700 |
1 |
|
|a Wiman, Klas G.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|